With five years of fitness data, MIT Sloan researchers show you run more when your friends run more.
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
Faculty joining MIT Sloan in 2023 are experts in energy markets, machine learning, health care economics, and decision-making.
A group of MIT Sloan faculty and students are using analytics to help senior homes stock up on protective gear and fill health care support roles.
Doctors need to trust their intuition, but a decision support tool can help them make hard choices.
Frederic Kerrest built a billion-dollar company around the concept of identity protection, but when it comes to ideas, he’s all about transparency.
Companies will compete Aug. 24 in Bangkok for a shot at the MIT Inclusive Innovation Challenge finals.
Sloan Distinguished Professor of Management, Professor, Marketing
Steve Rusckowski, SM ’84, former chairperson, CEO, and president of Quest Diagnostics, believes small changes can have a major impact on company culture.
The startup’s device could expand access, reduce cost, and reduce injection time for biologic drugs for cancer and autoimmune diseases.
